How the West Actually Talks About TCM

Most English-language writing about traditional Chinese medicine falls into one of two buckets. Either it cures everything, or it is pseudoscience and you are a fool for asking. Neither is much use if you are trying to work out what is actually going on.

This piece takes a third route. It does not argue that TCM works or does not work. It sets out three things you can check yourself: what the official documents actually say, where Western clinical guidelines actually place it, and where the money and the attention actually go. Then it says plainly where the disagreement sits.

1. The highest endorsement is a code, not a verdict

In May 2019 the World Health Assembly adopted ICD-11. Chapter 26 of that revision is a traditional medicine chapter — Module I covers conditions originating in ancient China and now commonly used in China, Japan, Korea and elsewhere. Member states could start reporting with it from 2022.

This is the item most often quoted as proof that “the WHO recognises TCM”. It is worth reading what the WHO wrote beside it, in its own FAQ:

“The Traditional Medicine Chapter is neither judging nor endorsing the scientific validity of any Traditional Medicine practice or the efficacy of any Traditional Medicine intervention.”

That is not a hedge buried in a footnote. It sits in the same paragraph as the chapter’s purpose. What the chapter does is give statisticians and insurers a vocabulary: it allows optional dual coding in morbidity data, so a clinic visit can be recorded two ways; it feeds reimbursement, adverse-event reporting, patient safety and research. It is explicitly not used for mortality statistics.

So the honest reading runs in both directions. “The WHO endorses TCM” is wrong. But “it is just paperwork” is also half wrong, because a code is what lets a treatment enter an insurance system, an electronic health record, or a safety-reporting chain. Infrastructure is not a verdict, but nothing scales without it.

If you want the strongest scientific recognition any TCM-derived substance has received, it is not that chapter. It is 2015, when the Nobel Prize in Physiology or Medicine went partly to Tu Youyou for artemisinin, an antimalarial compound isolated after reading a fourth-century Chinese text on treating fever. Notice what the prize actually rewarded: not the tradition, but the isolation, the testing and the trials that turned a historical hint into a drug. That distinction is the whole argument in miniature.

2. Where Western guidelines actually put acupuncture

Guidelines are a better signal than press releases, because a guideline committee has to defend its wording to people who will be judged for following it.

American College of Physicians, 2017. For chronic low back pain, acupuncture appears among the non-drug options recommended as first-line treatment. It is also listed for acute low back pain.
American College of Rheumatology and the Arthritis Foundation, 2019. Acupuncture is conditionally recommended for osteoarthritis of the knee, hip or hand, with the strongest evidence base for the knee.
US Medicare, from 2020. Covers acupuncture for chronic low back pain — up to 12 visits, plus 8 more if the first 12 produce improvement.

Now the half that usually gets left out of the celebratory version. The same US National Center for Complementary and Integrative Health (NCCIH) that lists those findings also grades the evidence: low quality for acute low back pain, moderate for chronic. And it states the finding that matters most:

In many trials, acupuncture beats no treatment by a wider margin than it beats sham acupuncture — needling that does not penetrate, or retractable needles. The gap between those two comparisons is the size of the non-specific effect: expectation, ritual, and an hour spent lying down with someone paying attention to you. NCCIH writes this out in plain language rather than hiding it.

There is also a clean example of a practice that looked supported and then was not. The US Department of Defense and Department of Veterans Affairs have used “battlefield acupuncture”, a quick ear-needle protocol, for pain. A 2021 review of nine studies covering 692 participants found no significant improvement in pain compared with no treatment, usual care, delayed treatment or sham.

The pattern is consistent, and it contradicts both camps. Acupuncture appears in guidelines for a narrow band of conditions, mostly pain, on evidence described as low to moderate, with a measurable non-specific component. That is neither a broad endorsement nor a dismissal.

3. Who actually pays

Follow the money, because payment is the hardest signal to fake. A survey can be gamed; a budget line cannot.

Use more than doubled. Among US adults, acupuncture use went from 1.0% in 2002 to 2.2% in 2022, according to National Health Interview Survey data cited by NCCIH.
Insurance caught up. The share of adult acupuncturist visits with any insurance coverage rose from 41.1% in 2010–2011 to 50.2% in 2018–2019.
It is not a Western-only practice. The WHO reports acupuncture in use in 103 of the 129 countries that submitted data.

Safety regulation also tells you how the technology is classified. The US FDA regulates acupuncture needles as medical devices, requiring sterile, single-use labelling. Reported complications are relatively few and come overwhelmingly from non-sterile needles and poor technique — infections, punctured organs, injury to the central nervous system. The risk profile is that of a procedure, not a pill, which is why practitioner licensing matters more than brand name.

4. What actually went viral

This is where the numbers get soft, so treat them as directional.

The Olympic moment. In August 2016, Michael Phelps arrived at the Rio pool with dark circles across his shoulders. Within hours the marks were the most-discussed thing at the Games that was not a race. Outlets at the time counted roughly 30 tweets a minute at the peak. Teammates and rivals followed: US gymnast Alex Naddour told USA Today that his set of cups cost about $15 on Amazon and called it the secret to staying healthy; Belarusian swimmer Pavel Sankovich posted that cupping was “a great recovery tool”. Whatever you think of the mechanism, that fortnight moved cupping out of alternative-medicine clinics and into the mainstream vocabulary.

The practitioner accounts. The most durable social presence is not celebrity, it is licensed clinicians explaining anatomy in fifteen seconds. Li Qianlei (@oldtown_acupuncturist), a US-licensed acupuncturist with degrees in biomedicine and TCM, built roughly 590,000 followers on TikTok; one clip about a single point passed 8.7 million views. Kathy (@kathyhealthtips), a California-licensed acupuncturist with a pharmacy background, passed 1.7 million followers and ten million likes. Both do the same thing: point at a body part, name it, show a motion you can copy at your desk.

The product side. Gua sha tools moved from TCM shops into cosmetics retail, priced roughly $20–80 and frequently sold out. Herbal teas, foot-soak packs and moxa products took the same path: repackaged as wellness, kept away from the word medicine.

Why the view counts disagree. Platform hashtag totals are not public data. Analytics vendors scrape different surfaces and publish figures for the same tag that differ by an order of magnitude — you will find #acupuncture described as 200 million, 360 million and 2 billion views in write-ups published within a year of each other. Any article quoting one confident number is quoting an estimate. What is stable is the format that travels: short, imitable, with immediate visible feedback — a red mark, a bruise, a twitch, a “that actually felt looser”. The format, not the total, is the real finding.

5. The Games did more than any advertisement

If you want to know where Western audiences actually met these therapies, the answer is not a journal. It is a stadium, four times in the last decade. One caveat before the detail: a clinic inside an athletes’ village is a convenience, not a trial. Free treatment, a five-minute walk from the dining hall, and a sore shoulder are not evidence that anything works. What they are evidence of is acceptability — and that is what anyone selling into this category is actually selling.

Rio, 2016. Michael Phelps, Alex Naddour, Pavel Sankovich. The marks had been spreading for longer than television suggested: Natalie Coughlin, the American swimmer who first recommended cupping to Phelps, picked the habit up from the Australian team back in the early 2000s. On the day The Guardian covered it, Google Trends logged a 2,100% jump in searches for “circles on Michael Phelps”.

Beijing, 2022. This one was organised rather than accidental. All three Winter Olympic villages ran a polyclinic, and the Yanqing one was led by Xuanwu Hospital with 193 staff drawn from institutions including the Beijing Hospital of Traditional Chinese Medicine. Its TCM department offered acupuncture, tuina massage, bone-setting and acupressure — and the accounts are specific enough to check. American Samoa’s skeleton athlete Nathan Crumpton returned for a third session and said the pain in his lower back and right leg had eased. A national delegation chief arrived with severe low back and leg pain, was close to pain-free after three rounds, and came back with two team-mates who wanted the same. An IOC official with acute low back pain was treated with massage and microwave therapy, and wrote that spinal movement had returned to normal. By the closing ceremony the clinic had a stack of thank-you notes written on packing cartons, which the staff called “the Olympic friendship tower”.

Hangzhou, 2023. The Asian Games village polyclinic listed 16 clinical departments, one of them TCM tuina. Therapists reported 20 to 30 patients each per day, with cupping slots gone before noon. But the image that travelled was not a press release. Iran’s men’s table tennis team knocked out Japan 3-0 in the quarter-final, and the broadcast showed cupping marks across the players’ backs. Iran went on to take bronze — its first team medal at the Asian Games in 65 years. Chinese social media made the obvious joke, and that joke was a distribution channel no marketing budget buys.

Chengdu, 2025. The World Games put TCM clinics in both village zones, open from 9am to noon and 2pm to 9pm. The menu ran from cupping, moxa and acupressure to a needling technique listed as national intangible cultural heritage.

Four Games, four different organising committees, the same decision: put it inside the village. That is a choice made by the host, and it should be read as one. It tells you that a state is willing to spend money making the therapy ordinary, and that athletes from dozens of countries will walk in. Neither is a clinical result. Both are market facts.

6. The ones who fly in for it

The individual version of the same story is harder to file under public relations, because the patient pays for the flight.

The clearest numbers come from Sanya, at the southern tip of Hainan. Xinhua reported in January 2026 that Sanya Hospital of Traditional Chinese Medicine was treating close to 100 foreign patients at any one time — most from Mongolia, Russia, Spain, the United Arab Emirates, the United States and Canada — and that as of October 2025 the hospital had treated more than 100,000 overseas patients from over 40 countries. In the first half of 2026 its affiliated sanatorium alone received more than 8,000 international visitors.

One of them was a Russian patient named Nicholas, who had lived with chronic arthritis for five years. He had been treated in Russia and across Europe; relief never lasted. He found Hainan online, took two weeks off work and went. After half a month of physiotherapy he reported a clear improvement, and credited two things at once: “the doctors’ skills, together with the warm climate”. That second half matters. What Hainan offers is a package — visa-free entry for 59 countries, a warm winter, prices below a Western clinic, and a hospital with a dedicated international wing. The therapy cannot be separated from the trip, and nobody selling this should pretend it can.

The traffic runs the other way too. In 2026 a German orthopaedic surgeon travelled to Chengdu to study TCM at a hospital there, saying that in Europe — Switzerland especially — TCM clinics sit on nearly every high street, and that he intended to combine what he learned with conventional practice back home. On the supply side, Xinhua puts the number of mainland institutions offering international medical services at roughly 850, across 57 cities.

And there is a political case that rarely makes the lifestyle coverage. Hungary licensed 13 Chinese TCM practitioners in 2003, while Péter Medgyessy was prime minister. In December 2013 its parliament voted 259 to 73, with 7 abstentions, to create a legal route for TCM practitioners to work independently; the implementing rules followed in 2015. Medgyessy later chaired a foundation promoting TCM in Europe, and Hungarian coverage describes the country as the first in Europe to legislate for the practice. That is a Western health system deciding where the therapy belongs in law — a more consequential event than any photograph of a celebrity’s back.

None of it measures efficacy, and the reporting has an obvious limitation: the patient counts come from the hospitals themselves and from Chinese state media, and there is no independent audit behind them. Read them as evidence of demand, at scale, from people who paid to travel — not as evidence that the treatment worked. The honest summary is narrower and still interesting. A few hundred thousand people a year now cross borders for a category that Western medicine places, at best, in a narrow pain indication on low-to-moderate evidence.

7. Where the disagreement actually is

The opposition is not a monolith, and it is not mostly rude. The substantive objections are these:

Blinding is nearly impossible. You cannot convincingly pretend to insert a needle into someone. Trials are therefore structurally weaker than drug trials, and the sham-control design used to compensate is itself contested — a needle that touches skin may not be inert.
Results track the practitioner. Effect sizes vary more between practitioners than between protocols, which makes the technique hard to standardise and easy to over-claim.
Small samples, short follow-up. Many positive trials are underpowered, and long-term outcomes are thin.

When USA Today asked a New York physician about cupping in 2016, the answer was blunt — there is little to no scientific basis. But he added two things that rarely make the headline: the research exists and is simply not good enough, and the psychological effect can still produce a genuine change in how someone feels. Both halves together are the position. The argument is not really “does it work”. It is “what standard of evidence should a two-thousand-year-old practice be held to, and who decides”.

8. What this means if you buy or sell these goods

Strip the ideology and a real, growing consumer category is left: gua sha boards, silicone and glass cupping sets, moxa rolls and boxes, massage rollers, herbal tea blends, foot-soak sachets, acupressure mats. Almost all of it is hardware, houseware or food. Almost none of it is a medicine. That line decides everything downstream.

Claims move the product into a different regime. A glass cup sold as a massage tool is a low-risk device or a household item. The same cup sold as treating a named disease may be a medical device needing a conformity-assessment file, or in some markets an unapproved medicine. The object did not change. The sentence on the box did.
Herbal products split two ways. In the EU, a herbal product making medicinal claims generally needs registration under the traditional herbal medicinal products regime, which requires evidence of 30 years of use, 15 of them inside the EU. In the US, the same botanical more often ships as a dietary supplement under DSHEA — permitted to carry structure or function statements, not disease claims.
Labelling is the failure point, not manufacturing. In this category more listings get pulled over a sentence than over a defect. If you are sourcing, ask for the artwork before you ask for the sample.

None of that requires an opinion about qi. It requires knowing which box your product is being sold in.

Short version

The WHO gave the field a classification code and explicitly refused to endorse efficacy. Western guidelines place acupuncture as a first-line option inside a narrow pain indication, on low-to-moderate evidence. Insurers started paying for part of it. Social platforms turned the visible, imitable parts — cupping, gua sha, point pressing — into a decade-long content category whose view counts nobody can verify. Four multi-sport events put it in front of athletes from dozens of countries, and one hospital in Sanya counts more than 100,000 overseas patients. Demand is no longer the uncertain part. The argument that remains is about evidence standards, not about belief.

If you are in the trade, sell the object as an object, and keep medical claims off the packaging. The heat is real. So is the recall.

This article describes public documents and published research. It is not medical advice, and it makes no claim about whether any of these practices treats any condition.